|Title:||Anti-Albuminuric Effects of the Angiotensin AT1 Receptor Blocker Telmisartan in Hypertensive Patients||Authors:||Rodriguez-Perez, Jose C.
Garcia-Bello, Miguel A.
Novoa-Mogollon, Francisco J.
Prevention, et al
|Issue Date:||2011||Publisher:||1064-1963||Journal:||Clinical and Experimental Hypertension||Abstract:||We evaluated the anti-hypertensive and anti-albuminuric effect of the angiotensin receptor blocker telmisartan alone and in combination with torasemide and amlodipine. Patients were hypertensive, both diabetics and non-diabetics with persistent microalbuminuria. Our primary endpoint was a change in microalbuminuria levels, while the secondary endpoints were changes in systolic blood pressure (SBP), diastolic blood pressure (DBP), serum creatinine levels, and glomerular filtration rate. After the 16-week treatment period, the patients significantly reduced microalbuminuria levels (76.4 +/- 52.4 mu g/min; p < 0.001), SBP (16.4 +/- 8.7 mmHg; p < 0.001) and DBP (17.7 +/- 5.9 mmHg; p < 0.001). Both diabetics and non-diabetics showed an identical pattern of significance with respect to the whole population. Systolic blood pressure, DBP, and microalbuminuria were significantly reduced as a consequence of therapy, both in diabetics and non-diabetics.||URI:||http://hdl.handle.net/10553/53000||ISSN:||1064-1963||DOI:||10.3109/10641963.2011.561900||Source:||Clinical And Experimental Hypertension[ISSN 1064-1963],v. 33 (8), p. 506-510|
|Appears in Collections:||Artículos|
Items in accedaCRIS are protected by copyright, with all rights reserved, unless otherwise indicated.